Hospital Infection Therapeutics Market Report by Drug Type (Anti-bacterial Drugs, Anti-fungal Drugs, Anti-viral Drugs, and Others), Indication (Blood Stream Infections, Urinary Tract Infections, Surgical Site Infections, Pneumonia, and Others), and Region 2025-2033

Hospital Infection Therapeutics Market Report by Drug Type (Anti-bacterial Drugs, Anti-fungal Drugs, Anti-viral Drugs, and Others), Indication (Blood Stream Infections, Urinary Tract Infections, Surgical Site Infections, Pneumonia, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A2393

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Hospital Infection Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Type
    6.1    Anti-bacterial Drugs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Anti-fungal Drugs
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Anti-viral Drugs
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Indication
    7.1    Blood Stream Infections
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Urinary Tract Infections
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Surgical Site Infections
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Pneumonia
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9   SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10  Value Chain Analysis
11  Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12  Price Analysis
13  Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Allergan Plc (AbbVie Inc.)
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio 
           13.3.1.3 Financials 
           13.3.1.4 SWOT Analysis
        13.3.2    AstraZeneca Plc
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Bayer Aktiengesellschaft
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio 
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Bristol-Myers Squibb Company
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio 
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    F. Hoffmann-La Roche AG (Roche Holding AG)
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio 
           13.3.5.3 SWOT Analysis
        13.3.6    Gilead Sciences Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio 
           13.3.6.3 Financials 
           13.3.6.4 SWOT Analysis
        13.3.7    GlaxoSmithKline Plc
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials 
           13.3.7.4 SWOT Analysis
        13.3.8    Johnson & Johnson
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio 
           13.3.8.3 Financials 
           13.3.8.4 SWOT Analysis
        13.3.9    Merck & Co. Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials 
           13.3.9.4 SWOT Analysis
        13.3.10    Pfizer Inc.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio 
           13.3.10.3 Financials 
           13.3.10.4 SWOT Analysis
        13.3.11    Sanofi S.A.
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio 
           13.3.11.3 Financials 
           13.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Hospital Infection Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Hospital Infection Therapeutics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Hospital Infection Therapeutics Market: Breakup by Drug Type (in %), 2024
Figure 4: Global: Hospital Infection Therapeutics Market: Breakup by Indication (in %), 2024
Figure 5: Global: Hospital Infection Therapeutics Market: Breakup by Region (in %), 2024
Figure 6: Global: Hospital Infection Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 7: Global: Hospital Infection Therapeutics (Anti-bacterial Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Hospital Infection Therapeutics (Anti-bacterial Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Hospital Infection Therapeutics (Anti-fungal Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Hospital Infection Therapeutics (Anti-fungal Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Hospital Infection Therapeutics (Anti-viral Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Hospital Infection Therapeutics (Anti-viral Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Hospital Infection Therapeutics (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Hospital Infection Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Hospital Infection Therapeutics (Blood Stream Infections) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Hospital Infection Therapeutics (Blood Stream Infections) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Hospital Infection Therapeutics (Urinary Tract Infections) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Hospital Infection Therapeutics (Urinary Tract Infections) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Hospital Infection Therapeutics (Surgical Site Infections) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Hospital Infection Therapeutics (Surgical Site Infections) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Hospital Infection Therapeutics (Pneumonia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Hospital Infection Therapeutics (Pneumonia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Hospital Infection Therapeutics (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Hospital Infection Therapeutics (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: North America: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: North America: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: United States: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: United States: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Canada: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Canada: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Asia Pacific: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Asia Pacific: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: China: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: China: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Japan: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Japan: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: India: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: India: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: South Korea: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: South Korea: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Australia: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Australia: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Indonesia: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Indonesia: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Others: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Others: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Europe: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Europe: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Germany: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Germany: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: France: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: France: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: United Kingdom: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: United Kingdom: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Italy: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Italy: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Spain: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Spain: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Russia: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Russia: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Latin America: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Latin America: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Brazil: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Brazil: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Mexico: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Mexico: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Others: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Others: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Middle East and Africa: Hospital Infection Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Middle East and Africa: Hospital Infection Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Global: Hospital Infection Therapeutics Industry: SWOT Analysis
Figure 74: Global: Hospital Infection Therapeutics Industry: Value Chain Analysis
Figure 75: Global: Hospital Infection Therapeutics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Hospital Infection Therapeutics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Hospital Infection Therapeutics Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
Table 3: Global: Hospital Infection Therapeutics Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 4: Global: Hospital Infection Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Hospital Infection Therapeutics Market Structure
Table 6: Global: Hospital Infection Therapeutics Market: Key Players

Hospital Infection Therapeutics Market Report by Drug Type (Anti-bacterial Drugs, Anti-fungal Drugs, Anti-viral Drugs, and Others), Indication (Blood Stream Infections, Urinary Tract Infections, Surgical Site Infections, Pneumonia, and Others), and Region 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials